Home / Capabilities

Capabilities

Integrated technology platforms and deep mitochondrial expertise, from early screening to decision-ready data.

Technologies

Innovating the Next Generation of Screening Technologies

We develop breakthrough screening technologies designed to push the boundaries of what is possible in drug discovery. By combining novel approaches to biological measurement with advanced imaging, sensing and data technologies, we seek to uncover new ways of understanding cellular function, drug response and toxicity. Our focus is on creating more sensitive, functional and informative screening approaches that enable earlier insight and help drive the next generation of medicine.

Solutions

End-to-End Proprietary Technologies & Integrated Discovery Capabilities

Our proprietary technology stack brings together advanced screening, flow cytometry, microscopy, functional assay development, data aggregation and toxicity discovery within a single, integrated platform. These complementary capabilities enable us to move from biological measurement and early-stage screening through to actionable data and discovery — providing researchers with deeper functional insight, earlier identification of risk and greater confidence in advancing the most promising candidates.

Our Mission

Mitochondria at the Heart of Drug Development

Our mission is to put mitochondrial biology at the forefront of drug discovery, enabling earlier, more informative screening and a deeper understanding of drug-induced toxicity. By developing innovative technologies that reveal functional changes in mitochondrial biology, we aim to improve how potential medicines are identified, characterised and prioritised — helping researchers make better decisions earlier, reduce late-stage failures and ultimately accelerate the discovery of safer, more effective medicines.

Our technologies driving discovery

Next-generation platforms that enable smarter drug discovery, deeper biological insight, and earlier prediction of mitochondrial toxicity.

Mitochondrial research pipeline: advanced technologies, data collection and monitoring, gain/loss-of-function insights, toxicity assessment and drug discovery
01

Advanced technologies, data collection & monitoring

Platforms that capture how cells use energy and respond to compounds.

02

Gain/loss-of-function insights

Functional readouts that show how mitochondrial behavior changes.

03

Toxicity assessment & drug discovery

Evidence to flag mitochondrial liabilities and guide candidate selection.

End-to-End Drug Discovery Support

From target identification and validation to HTS, hit discovery, lead optimisation and candidate evaluation, we design and execute bespoke discovery projects across the full spectrum of in vitro and in cellulo biology.

Our multimodal approach integrates primary and disease-relevant models, phenotypic and mechanistic assays, advanced screening technologies, and toxicity profiling to deliver comprehensive, decision-ready datasets tailored to each project.

Technology Capabilities

Our integrated technology platforms support every stage of therapeutic discovery, from early target validation and compound screening to functional characterisation and safety assessment.

We combine advanced screening technologies with deep expertise in mitochondrial biology to deliver high-quality, actionable data.

Our Capabilities Include

01

Flow Cytometry

High-parameter cellular analysis and phenotypic profiling.

02

In Vitro Screening

Enzyme activity, substrate conversion, inhibitor identification, and potency assessment.

03

High-Throughput Screening

Scalable screening for large compound libraries and lead identification.

04

In Cellulo Therapeutic Profiling

Functional assessment of therapeutic candidates in physiologically relevant cellular models.

05

Mitochondrial Function & Metabolic Profiling

Comprehensive analysis of mitochondrial health, cellular bioenergetics, and metabolic activity.

06

Mitochondrial Toxicity Screening

Early detection and characterisation of mitochondrial liabilities to improve candidate selection.

07

High-Content Imaging

Multiparametric imaging to quantify cellular phenotypes, organelle dynamics, and drug responses.

08

Mechanism of Action Studies

Functional assays to investigate target engagement and biological response.

09

In Vitro & In Cellulo Assays

Flexible assay formats spanning biochemical, cellular, and translational applications.

10

Data Analysis & Scientific Interpretation

Comprehensive reporting with expert biological insight to support confident decision-making.